Avsnitt

  • Visceral Fat - The Hidden Fat That Drives Insulin Resistance

    Visceral Fat - The Hidden Fat That Drives Insulin Resistance

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    In this lecture, Dr. Ben Bikman explains why visceral fat is one of the most metabolically dangerous forms of body fat. Unlike subcutaneous fat, which sits under the skin and can be pinched, visceral fat is stored deep inside the abdomen around the organs. Its location matters because visceral fat drains directly into the liver through the portal vein, meaning the fatty acids and inflammatory signals it releases reach the liver first and at high concentration.


    Dr. Bikman explains that visceral fat is especially harmful because it tends to grow through hypertrophy, meaning existing fat cells get larger rather than new smaller fat cells being created. As these fat cells enlarge, they become insulin resistant and begin leaking fatty acids even when insulin should be suppressing fat release. Those fatty acids can then accumulate in the liver, pancreas, and muscle, contributing to ectopic fat storage, fatty liver disease, and worsening insulin resistance.


    The lecture also highlights how enlarged visceral fat cells can become hypoxic, or oxygen-starved, which pushes them to release inflammatory signals and recruit immune cells. This turns visceral fat into an active source of chronic low-grade inflammation. The hopeful takeaway is that visceral fat is also highly responsive to catecholamines, the hormones released during physical activity. Exercise can therefore help reduce visceral fat specifically, even when overall body weight does not change dramatically.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    #VisceralFat #InsulinResistance #FattyLiver #MetabolicHealth #BellyFat #Inflammation #EctopicFat #PortalVein #ExerciseScience #Catecholamines #SubcutaneousFat #FatCells #Hypoxia #MetabolicDisease #LowCarbScience #DrBenBikman #MetabolicClassroom #MetabolismMatters #HealthScience #FatLoss

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Your Bones Affect Your Metabolism

    Why Your Bones Affect Your Metabolism

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Bone is a metabolically active organ that responds to insulin and glucose while releasing hormones that influence the pancreas, fat cells, appetite, and energy use. High glucose and insulin resistance can make bones brittle despite normal density, while resistance training, stable glucose, and good nutrition support both skeletal and metabolic health.


    Summary:

    Dr. Bikman explains why bone should be understood as a metabolic organ, not just structural scaffolding. Bone is living tissue that is constantly being broken down and rebuilt by opposing teams of cells, and that remodeling process requires energy, nutrients, and hormonal coordination. Far from being inert, bone responds to metabolic signals such as insulin, glucose, and leptin—and it sends signals back to the rest of the body.


    Ben focuses first on insulin’s role in bone health. Insulin acts as a growth signal for bone-building cells, helping maintain bone density and structure. In type 1 diabetes, where insulin is absent, bone density and architecture suffer. In type 2 diabetes, the problem is different: bone density may look normal on a DEXA scan, but chronically high glucose can glycate collagen, making bone stiffer and more brittle. At the same time, insulin resistance weakens the bone-building signal, creating the “diabetic bone paradox,” where bones appear dense but fracture more easily.


    The lecture then explores bone-derived hormones, especially osteocalcin and lipocalin-2. Osteocalcin can support insulin secretion under glucose stimulation, increase adiponectin from fat cells, improve insulin sensitivity, reduce inflammation, and promote fat burning. Lipocalin-2 travels from bone to the brain after meals and appears to help suppress appetite while also supporting glucose regulation. The practical takeaway is that metabolic health and bone health are deeply connected: stable glucose, good insulin sensitivity, vitamin K, resistance training, and weight-bearing movement all help protect the skeleton and support whole-body metabolism.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • Saknas det avsnitt?

    Klicka här för att uppdatera flödet manuellt.

  • Why Some People Burn More Calories Than Others

    Why Some People Burn More Calories Than Others

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    In this Metabolic Classroom episode, Dr. Bikman explains mitochondrial uncoupling, a process where cells burn fuel without converting all of that energy into usable ATP. Normally, mitochondria are “coupled,” meaning fuel burning is efficiently converted into cellular energy. But when mitochondria become uncoupled, some of that fuel is released as heat instead—like revving a car engine while it’s in park.


    Ben explains that this process is especially important in fat tissue. White fat is designed for energy storage and tends to be tightly coupled, while brown fat is rich in mitochondria and uncoupling proteins that burn fuel to generate heat. He then connects this physiology to insulin, showing that insulin appears to make fat-cell mitochondria more tightly coupled and efficient, lowering energy expenditure and making storage easier.


    The opposite happens when insulin is low and ketones rise. Research from Dr. Bikman’s lab shows that ketones, especially beta-hydroxybutyrate, can increase mitochondrial respiration in fat cells without a matching rise in ATP production—clear evidence of uncoupling. In human fat biopsies, elevated ketones were associated with markedly higher mitochondrial respiration, suggesting that ketosis can make fat tissue more wasteful with energy.


    The larger takeaway is that calories still matter, but hormones influence how efficiently those calories are stored or burned. When insulin is high, the body stores energy efficiently. When insulin is low and ketones are elevated, fat-cell mitochondria may become more uncoupled, allowing more energy to be dissipated as heat rather than stored as fat.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Amylin May Be the Most Important Weight Loss Hormone You've Never Heard Of

    Why Amylin May Be the Most Important Weight Loss Hormone You've Never Heard Of

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Amylin is an insulin-sparing satiety hormone released with insulin that slows digestion, restrains glucagon, and helps reduce post-meal glucose spikes. New amylin-based therapies, especially when combined with GLP-1 drugs, may offer powerful weight-loss effects by restoring natural fullness signals rather than forcing insulin higher.


    Summary:

    In this lecture, Dr. Bikman explains amylin, a hormone released from the pancreatic beta cell alongside insulin. While insulin helps move nutrients into tissues, amylin works mainly through the brain and digestive tract to increase fullness, slow gastric emptying, restrain post-meal glucagon, and reduce blood sugar spikes without forcing insulin higher. This makes amylin an insulin-sparing hormone and a natural complement to GLP-1.


    Ben explains why amylin was difficult to turn into a drug: human amylin naturally tends to misfold and form amyloid deposits in the pancreas. Protein engineering solved this problem by creating analogs that activate the amylin receptor without clumping. The first amylin-based drug, pramlintide, proved the concept by reducing appetite, slowing digestion, blunting post-meal glucose rises, and producing modest weight loss, though its short duration and nausea limited broader use.


    The lecture then moves into newer amylin-based therapies, especially cagrilintide and the combination drug CagriSema, which pairs cagrilintide with semaglutide. Because amylin and GLP-1 work through overlapping but distinct brain pathways, the combination produces greater weight loss than either hormone strategy alone. The takeaway is that amylin may become one of the most important next-generation targets in metabolic medicine because it supports satiety and glucose control without driving insulin higher.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Your Ketone Readings Don’t Match

    Why Your Ketone Readings Don’t Match

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Note:

    Our friends at SiBio CKM are offering a 5% discount using the code BEN5 at checkout. However, their CKM is not yet available in the United States and Canada. It is currently available in selected countries including the UK, Australia, Ireland, the Netherlands, and Germany. You can view the full list of supported countries on their website. Also, you can submit your email on their website and they will notify you when it becomes available in your region: https://www.sibiosensor.com/BEN5


    Summary:

    Ben explains the four major ways to measure ketones: urine strips, breath analyzers, finger-prick blood meters, and the newer continuous ketone monitor. He begins by reviewing the three ketone bodies produced during fat-based metabolism: acetoacetate, beta-hydroxybutyrate (BHB), and acetone. Each testing method measures a different ketone molecule, which explains why results often do not match across devices.


    Urine strips measure acetoacetate, making them inexpensive and useful early in a ketogenic diet, but they become less reliable as the body adapts and uses ketones more efficiently. Breath analyzers measure acetone, offering a reusable and non-invasive option, but they are vulnerable to breathing technique, alcohol, environmental compounds, and imperfect correlation with blood BHB. Blood meters measure BHB directly and remain the practical gold standard for spot-checking nutritional ketosis, but they require finger pricks and costly strips.


    The newest tool is the continuous ketone monitor, which measures BHB in interstitial fluid and provides hundreds of readings per day. Dr. Bikman explains that this makes it possible to see trends, overnight patterns, meal responses, supplement effects, and individual variability in a way that spot-check methods cannot capture. The practical takeaway is that continuous ketone monitoring changes the question from “What are my ketones right now?” to “How does my body respond over time?”


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    #Ketones #KetoneTesting #ContinuousKetoneMonitor #CKM #BetaHydroxybutyrate #BHB #Ketosis #MetabolicHealth #KetoScience #LowCarbScience #FatAdaptation #UrineKetones #BreathKetones #BloodKetones #MetabolicFlexibility #HealthTracking #DrBenBikman #MetabolicClassroom #KetogenicDiet #MetabolismMatters


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Retatrutide May Outperform GLP-1 Drugs

    Why Retatrutide May Outperform GLP-1 Drugs

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Retatrutide activates GLP-1, GIP, and glucagon receptors, combining appetite suppression with increased energy expenditure and powerful liver fat reduction. Dr. Bikman argues that its best use is not as a permanent shortcut, but as a tool to help people regain control over food habits and eventually reduce reliance on medication.


    Summary:

    Dr. Ben Bikman explains retatrutide, a next-generation metabolic drug that activates three receptors at once: GLP-1, GIP, and glucagon. While semaglutide targets GLP-1 and tirzepatide targets GLP-1 plus GIP, retatrutide adds a third arm through glucagon receptor activation. This makes it distinct because GLP-1 and GIP mainly reduce food intake, while glucagon adds an energy-output effect by increasing fat oxidation, liver fat clearance, and energy expenditure.


    Dr. Bikman focuses especially on glucagon because it is the novel feature of retatrutide. In the liver, glucagon stimulates fat burning, suppresses new fat production, promotes hepatic fat clearance, and increases energy expenditure through futile cycling and FGF21 signaling. Human trials show remarkable reductions in body weight and liver fat, with some studies reporting over 80% relative reductions in hepatic fat content and nearly 90% of treated participants reaching normal liver fat levels.


    He also explains that glucagon receptors are not expressed on skeletal muscle, which means the drug’s glucagon arm should not directly signal muscle breakdown. Instead, the liver and fat tissue respond while muscle largely ignores the glucagon signal. The practical takeaway is that retatrutide may represent the next major step in incretin-based therapy, but Dr. Bikman emphasizes again that these drugs should ideally be used as a temporary tool—a crutch—to help people reduce cravings, relearn eating patterns, and ultimately rely less on medication over time.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Tirzepatide Works Better Than GLP-1 Alone

    Why Tirzepatide Works Better Than GLP-1 Alone

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Tirzepatide activates both GLP-1 and GIP receptors, producing weight loss primarily through appetite suppression, slower gastric emptying, reduced cravings, and improved insulin sensitivity—not by forcing the pancreas to make more insulin. Dr. Bikman argues that its best use may be as a temporary tool to help people regain control of food choices and lower the insulin-driving habits that caused metabolic dysfunction.


    Summary:

    In this mini-lecture, Dr. Bikman explains tirzepatide, the dual-incretin drug that activates both GLP-1 and GIP receptors. While it is often described as a drug that improves glucose by increasing insulin, Dr. Bikman argues that this explanation misses the bigger metabolic picture.


    He begins by reviewing the incretin effect, where oral glucose produces a stronger insulin response than the same glucose given intravenously because the gut releases hormones such as GLP-1 and GIP. GLP-1 reduces appetite, slows gastric emptying, suppresses glucagon, and helps regulate glucose, while GIP has traditionally been viewed as more fat-storing because of its actions on fat cells.


    Ben then resolves the “GIP paradox”: blocking GIP can cause weight loss in animals, yet activating GIP through tirzepatide also causes weight loss. The key, he argues, is insulin. GIP can amplify fat storage only when insulin is elevated, but tirzepatide lowers fasting insulin, reduces meal-related insulin demand, and reduces cravings for foods that drive insulin high. In that lower-insulin context, GIP may support healthier fat tissue function, improve adiponectin, reduce adipose hypoxia, and allow higher GLP-1 activity with better tolerability.


    The practical takeaway is that tirzepatide should not be viewed as a magic weight-loss injection or a permanent substitute for lifestyle change. Used wisely, it may serve as a temporary tool to reduce carbohydrate cravings, improve satiety, lower insulin demand, and help people relearn healthier eating patterns.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • The Hidden Signals That Make Fat Cells Grow

    The Hidden Signals That Make Fat Cells Grow

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Nuclear receptors inside fat cells respond to lipid-soluble signals and help determine whether cells become fat cells and how they store energy. Although drugs, dietary fats, cortisol, and environmental chemicals can influence these receptors, insulin remains the dominant upstream signal controlling fat-cell growth and storage.


    Summary:

    Dr. Ben Bikman explains how nuclear receptors influence fat cell development, fat storage, and metabolic health. Nuclear receptors are proteins inside the cell nucleus that respond to small lipid-soluble signals—such as fatty acids, bile acids, thyroid hormone, cortisol, and steroid hormones—and translate those signals into changes in gene expression. In fat cells, these receptors help determine whether a precursor cell becomes a fat cell and how that fat cell behaves once it exists.


    The main focus is PPAR gamma, the master regulator of adipogenesis, or the formation of new fat cells. Ben emphasizes that insulin sits upstream of this entire process: insulin drives PPAR gamma expression and orchestrates the fat-cell-building program.


    The lecture then connects this biology to diabetes drugs known as TZDs, which activate PPAR gamma to improve insulin sensitivity by creating more small, functional fat cells. While this can improve blood glucose control and raise adiponectin, it often causes fat gain. Ben also discusses how dietary fatty acids can modestly influence PPAR gamma activity and how cortisol, acting through the glucocorticoid receptor, can promote visceral fat accumulation.


    The practical takeaway is that while we cannot avoid every chemical signal that touches these receptors, we can control the dominant upstream hormonal signal: insulin. Keeping insulin low and stable through carbohydrate control remains the most practical strategy for keeping fat-cell nuclear receptor signaling in a healthier state.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Neuropathy Isn’t Just About Blood Sugar

    Why Neuropathy Isn’t Just About Blood Sugar

    · The Metabolic Classroom with Dr. Ben Bikman

    Topic: Peripheral neuropathy is not caused by high glucose alone, but by the combined effects of hyperglycemia, insulin resistance, and glycemic variability. Protecting nerves requires improving insulin sensitivity and reducing glucose swings—not just lowering A1C.


    Summary: Ben explains why peripheral neuropathy is not simply a “high blood sugar” problem. While hyperglycemia clearly damages nerves, the story is more complex—especially in type 2 diabetes, where intensive glucose control does not prevent neuropathy nearly as well as it does in type 1 diabetes. Dr. Bikman argues that neuropathy is driven by three interacting metabolic forces: chronic hyperglycemia, insulin resistance, and glycemic variability.


    He begins by defining peripheral neuropathy as damage to the nerves outside the brain and spinal cord, most commonly appearing first in the feet and toes because the longest nerves are often affected earliest. He then explains how excess glucose damages nerves through the sorbitol pathway, oxidative stress, glycation, and inflammation. But glucose is only one part of the problem.


    The second pillar is insulin resistance. Peripheral nerves and their support cells, especially Schwann cells, need insulin signaling to maintain healthy myelin and nerve repair. When insulin signaling fails, nerves lose an important trophic support system even before glucose becomes severely elevated. The third pillar is glycemic variability, or repeated glucose swings, which may damage nerves beyond what A1C alone can reveal.


    The key takeaway is that protecting nerves requires more than lowering average blood sugar. It requires improving insulin sensitivity, reducing glucose swings, stabilizing post-meal responses, and addressing the metabolic dysfunction that damages nerves from multiple directions.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • How Your Brain Talks to Your Pancreas (The Vagus Nerve Explained)

    How Your Brain Talks to Your Pancreas (The Vagus Nerve Explained)

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    The vagus nerve is a major communication line between the brain and abdominal organs, helping regulate liver glucose output, gut-brain signaling, and pancreatic insulin secretion. When this neural system is disrupted—by obesity, inflammation, surgery, or altered autonomic balance—nutrient handling and metabolic control can suffer.


    Summary:

    Dr. Bikman explores the vagus nerve and its role in nutrient handling, with special attention to the pancreas and insulin secretion. The vagus is the major neural pathway connecting the brain to the metabolic organs of the abdomen, including the gut, pancreas, and liver. Rather than acting only as a motor nerve, it is predominantly sensory, constantly relaying information from the viscera back to the brain while also carrying signals downward that shape digestion, glucose regulation, and hormone release.


    He explains how the vagus helps regulate liver glucose output, gut-brain communication, and pancreatic beta cell function. He highlights the cephalic phase insulin response, the small early release of insulin triggered by seeing, smelling, tasting, or anticipating food before blood glucose even rises. While this effect is more clearly established in animals than in humans, the evidence suggests it may play a meaningful role in normal meal handling and may be impaired in obesity and metabolic disease.


    The lecture also examines what happens when the vagus is altered surgically or electrically. Cutting or blocking the vagus can reduce insulin responses to oral glucose and meaningfully affect body weight and glycemic control, while stimulating it through external devices may influence autonomic tone and possibly metabolism. The larger takeaway is that the vagus nerve is not peripheral to metabolism—it is a central regulator of how the brain and abdominal organs coordinate nutrient handling.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    #VagusNerve #InsulinSecretion #MetabolicHealth #GlucoseControl #Pancreas #GutBrainAxis #ParasympatheticNervousSystem #AutonomicNervousSystem #CephalicPhaseInsulin #LiverMetabolism #GLP1 #HeartRateVariability #Neuroendocrinology #InsulinResistance #MetabolismMatters #DrBenBikman #MetabolicClassroom #BrainAndBody #NutrientHandling #HealthScience#HealthScience


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • The Muscle Biology Behind Diabetes Risk

    The Muscle Biology Behind Diabetes Risk

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Summary:

    In this lecture, Dr. Ben Bikman explores how skeletal muscle fiber type influences insulin sensitivity and diabetes risk. While muscle is the body’s largest site of insulin-stimulated glucose disposal, not all muscle behaves the same. Different fiber types carry different amounts of the molecular machinery needed to respond to insulin, take up glucose, store it, and burn it.


    He begins by distinguishing the two major muscle fiber types: type 1 slow-twitch and type 2 fast-twitch. Type 1 fibers are more oxidative, with greater mitochondrial density, while type 2 fibers are more glycolytic and fatigue more quickly. Importantly, type 1 fibers contain more insulin receptors, GLUT4 transporters, and key enzymes involved in glucose handling, helping explain why a higher proportion of these fibers is associated with better insulin sensitivity.


    Dr. Bikman then connects these differences to real-world metabolic risk. Studies show that individuals with fewer type 1 fibers can have significantly lower insulin sensitivity—even when they appear healthy by standard markers. He also explores how these patterns may contribute to ethnic differences in diabetes risk across populations.


    The key takeaway is that fiber type is not destiny. While genetics plays a role, exercise can improve muscle’s glucose-disposal capacity. Most importantly, total muscle mass matters more than fiber type alone, making resistance training a powerful tool for protecting metabolic health.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • How Insulin May Be Silencing Your GLP-1

    How Insulin May Be Silencing Your GLP-1

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Summary:

    GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time.


    Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1?


    Evidence shows that insulin-resistant, obese, prediabetic, and type 2 diabetic individuals consistently have a blunted GLP-1 response. Mechanistic studies indicate that chronic exposure to high insulin can make L-cells insulin resistant, reducing their ability to secrete GLP-1 when needed. This may create a vicious cycle: high insulin suppresses GLP-1, low GLP-1 removes metabolic brakes, and the resulting larger glucose and insulin spikes further worsen the problem over time.


    The lecture reframes GLP-1 deficiency as a potential consequence of chronic hyperinsulinemia rather than an isolated defect. While GLP-1 drugs can bypass this dysfunction and improve outcomes, they do not repair the underlying cause—making long-term strategies that lower chronically elevated insulin levels more fundamental.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Creatine Is One of the Most Important Brain Nutrients

    Why Creatine Is One of the Most Important Brain Nutrients

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Creatine supports brain function by rapidly regenerating ATP, making it essential for cognitive performance, especially under conditions of stress or low baseline levels. Clinical evidence shows it can improve memory, attention, mood, and resilience—particularly in vegetarians, older adults, women, and sleep-deprived individuals.


    Summary:

    Creatine is widely known as a muscle-building supplement, but in this lecture, Dr. Ben Bikman reveals its far more important and underappreciated role in brain function. Creatine acts as a rapid energy buffer through the phosphocreatine system, allowing brain cells to regenerate ATP within milliseconds during periods of high demand. Because the brain has extremely high energy needs and limited energy storage, this system is critical for maintaining cognitive performance, neurotransmitter signaling, and overall brain health.


    Dr. Bikman walks through the human clinical evidence showing that creatine supplementation can meaningfully improve cognitive function, particularly in individuals with lower baseline creatine levels or increased metabolic stress. These groups include vegetarians and vegans, older adults, and women—each of whom tend to have lower creatine availability or higher demand. Studies show improvements in memory, intelligence, attention, and executive function, especially when the brain is under strain, such as during sleep deprivation.


    The lecture also explores emerging research linking creatine to depression, traumatic brain injury, and neurodevelopmental disorders. In multiple randomized trials, creatine supplementation enhanced antidepressant responses, improved brain energy metabolism, and reduced cognitive impairment following sleep loss or injury. The overall message is clear: creatine is not just a performance supplement—it is a critical molecule for brain energy, cognition, and resilience under stress.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    #Creatine #BrainHealth #CognitivePerformance #MemoryBoost #MetabolicHealth #BrainEnergy #ATP #Phosphocreatine #SleepDeprivation #MentalPerformance #NeuroScience #DepressionTreatment #BrainMetabolism #SupplementScience #DrBenBikman #MetabolicClassroom #HealthOptimization #FocusAndMemory #BrainFuel #NutritionScience

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Gum Disease Raises Your Blood Sugar

    Why Gum Disease Raises Your Blood Sugar

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Most people think of gum disease as a local dental issue, but this lecture reveals a much broader and more consequential reality. Dr. Ben Bikman explains how the mouth serves as a gateway to systemic inflammation, particularly when periodontal disease allows bacteria and their toxic byproducts to enter the bloodstream. Once this happens, oral pathogens—especially P. gingivalis—can drive chronic inflammation, disrupt mitochondrial function, and contribute directly to insulin resistance.


    At the mechanistic level, Dr. Bikman outlines several pathways linking oral health to metabolic dysfunction. These include cytokine spillover (where inflammatory signals interfere with insulin signaling), direct degradation of insulin receptors by bacterial enzymes, dysregulation of liver glucose metabolism, and disruption of the gut microbiome. Together, these effects create a persistent inflammatory state that impairs glucose control and increases the risk of type 2 diabetes—even in individuals without obesity.


    The lecture also explores the strong epidemiological evidence supporting this connection, including studies showing that treating periodontal disease can significantly improve blood sugar control. Dr. Bikman further connects oral health to cardiovascular disease, highlighting how oral bacteria and endotoxins contribute to atherosclerosis. The takeaway is clear: oral health is not separate from metabolic health—it is a critical and often overlooked component of it.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • Ivermectin Explained: The Science Behind the Controversy

    Ivermectin Explained: The Science Behind the Controversy

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Ivermectin is a Nobel Prize-winning drug with emerging evidence showing it influences mitochondria, inflammation, and metabolic signaling pathways such as AMPK and FXR. While most data is still preclinical, its consistent mechanisms and strong safety record make it a compelling candidate for further research in cancer and metabolic disease.


    Summary:

    Ivermectin has become one of the most controversial drugs in recent years, but beneath the political noise lies a compelling scientific story. In this lecture, Dr. Ben Bikman examines ivermectin strictly through the lens of peer-reviewed research, highlighting its origins as a Nobel Prize-winning antiparasitic drug and exploring its expanding role in metabolism, mitochondrial function, inflammation, and cancer biology.


    A central theme of the lecture is ivermectin’s impact on mitochondria, particularly its ability to inhibit complex I of the electron transport chain. This disruption creates an energy crisis within cells, activates AMPK, suppresses mTOR signaling, and can ultimately trigger apoptosis in cancer cells. Notably, these effects appear to be selective, with cancer cells showing greater sensitivity than healthy cells. Additional mechanisms—including inhibition of PAK1 and synergy with existing chemotherapy agents—further support ivermectin’s potential as a therapeutic candidate in oncology.


    Beyond cancer, ivermectin demonstrates meaningful metabolic effects. It reduces inflammation through suppression of NF-kappaB, activates AMPK, and influences glucose metabolism via FXR signaling. Preclinical studies show improvements in insulin sensitivity, glucose control, liver health, and even adipocyte behavior. While human data is still limited, Dr. Bikman emphasizes that the mechanistic consistency across pathways warrants serious clinical investigation rather than dismissal.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • How Sleep Loss Rewires Your Hunger Hormones

    How Sleep Loss Rewires Your Hunger Hormones

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Sleep loss alters key hunger hormones—reducing leptin and increasing ghrelin—while simultaneously activating reward pathways that increase cravings for calorie-dense foods. Because sleep and appetite hormones influence each other in both directions, improving sleep quality may be one of the most powerful tools for regulating hunger and metabolic health.


    Summary:

    Sleep is often treated as a simple lifestyle choice, but in reality it is one of the most powerful regulators of appetite and metabolic health. In this lecture, Dr. Ben Bikman explains the intricate hormonal relationship between sleep and hunger, highlighting how even short periods of sleep deprivation can dramatically alter the body’s appetite signals. Key hormones such as leptin and ghrelin shift in opposite directions during sleep restriction—satiety signaling declines while hunger signaling increases—creating a biological drive to eat more food.


    Ben also explores how sleep deprivation affects additional systems involved in appetite regulation, including the endocannabinoid system, cortisol rhythms, and the brain’s orexin neurons. These changes don’t just increase hunger—they specifically increase cravings for energy-dense, rewarding foods like chips, sweets, and other highly palatable options. Together, these hormonal changes create what researchers describe as an “obesogenic environment,” where the body becomes biologically primed to overeat.


    Importantly, the relationship works both ways. Hormones such as leptin and ghrelin also influence sleep quality, while melatonin plays a coordinating role in regulating the entire circadian system. Dr. Bikman concludes by emphasizing that optimizing sleep—especially protecting early-night deep sleep and minimizing artificial light at night—may be one of the most effective interventions for regulating appetite and improving metabolic health.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    #SleepAndMetabolism #SleepAndHunger #Ghrelin #Leptin #SleepDeprivation #MetabolicHealth #CircadianRhythm #EndocannabinoidSystem #SleepScience #HormonesAndSleep #InsulinResistance #AppetiteHormones #SleepAndWeightGain #CortisolRhythm #MelatoninScience #SleepQuality #MetabolismMatters #DrBenBikman #MetabolicClassroom #SleepForHealth


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • Why Alzheimer’s May Be a Metabolic Disease

    Why Alzheimer’s May Be a Metabolic Disease

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Alzheimer’s disease has traditionally been explained by the buildup of amyloid plaques in the brain, but growing evidence suggests this theory does not fully account for the disease or lead to effective treatments. A metabolic perspective proposes that Alzheimer’s may instead be driven by brain insulin resistance, which disrupts neuronal energy metabolism—while the brain’s ability to use ketones as an alternative fuel remains intact, offering potential strategies for prevention and support.


    Summary:

    For decades, Alzheimer’s disease has largely been understood through the lens of the amyloid plaque hypothesis, which proposes that sticky protein deposits in the brain trigger neurodegeneration and cognitive decline. In this Metabolic Classroom lecture, Ben explains why that theory is increasingly being questioned. He reviews the historical origins of the plaque hypothesis and the repeated failure of drugs designed to remove amyloid plaques to meaningfully improve patient outcomes. The controversy surrounding manipulated data in influential Alzheimer’s research further highlights the need for a new framework to better explain the disease.


    Ben then presents a compelling alternative: Alzheimer’s disease as a metabolic disorder driven by brain insulin resistance. Drawing from mechanistic studies, epidemiological data, and genetic insights, he explains how impaired insulin signaling in the brain can disrupt neuronal energy metabolism, increase tau tangles, impair amyloid clearance, and ultimately contribute to neurodegeneration. This concept has led some researchers to refer to Alzheimer’s as “Type 3 diabetes.”


    The lecture also explores a hopeful implication of this metabolic framework. While glucose metabolism is impaired in Alzheimer’s brains, research shows that the brain’s ability to use ketones remains intact. This suggests that strategies that improve insulin sensitivity or increase ketone availability—such as carbohydrate restriction, fasting, exercise, or exogenous ketones—may offer promising avenues for prevention or metabolic support.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    #AlzheimersDisease #Type3Diabetes #BrainInsulinResistance #MetabolicHealth #InsulinResistance #BrainHealth #CognitiveDecline #DementiaPrevention #KetonesForBrain #KetogenicScience #LowCarbScience #APOE4 #Neurodegeneration #BrainEnergy #MetabolicDisease #PreventAlzheimers #DrBenBikman #MetabolismMatters #Ketones #BrainMetabolism 


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • The Personal Fat Threshold Explained and Ethnicity’s Impact

    The Personal Fat Threshold Explained and Ethnicity’s Impact

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Metabolic disease is driven more by fat cell size and adipose tissue dysfunction than by total body fat. Ethnicity, genetics, and personal fat storage capacity determine when fat becomes metabolically dangerous.


    Summary:

    Dr. Bikman explores a profound but underappreciated truth in metabolic health: it is not how much fat you have that determines disease risk — it is how your fat is stored and how large your fat cells become.


    Using the metabolic paradox between the United States and Singapore as a starting point, Dr. Bikman explains why populations with dramatically different obesity rates can have nearly identical rates of type 2 diabetes. The key insight is that fat mass alone does not determine metabolic health. Instead, the size of individual fat cells and the body’s capacity to safely expand subcutaneous fat storage — what’s called the adipose expandability hypothesis — determines whether fat becomes harmful.


    White adipose tissue can expand in two ways: hypertrophy or hyperplasia. Hypertrophic fat cells become insulin resistant, release excessive free fatty acids even in the presence of insulin, promote ectopic fat deposition in the liver, and trigger chronic inflammation through hypoxia and HIF-1Îą signaling. This cascade drives fatty liver disease, systemic insulin resistance, and eventually type 2 diabetes.


    By contrast, hyperplastic expansion allows fat to be stored safely in small, metabolically healthy fat cells with normal vascularity and hormone signaling. This distinction explains why some individuals can carry more total fat yet remain metabolically healthy.


    Next is the concept of a personal fat threshold, largely influenced by genetics and ethnicity. South and East Asian populations tend to have a lower threshold for safe subcutaneous fat storage, meaning metabolic dysfunction can occur at lower BMIs compared to Europeans or Africans. This makes universal BMI cutoffs inadequate for assessing risk across ethnic groups.


    Finally, he discusses two more academic but mechanistically precise markers of fat cell health: the adiponectin-to-leptin ratio and the Adipo-IR index (fasting insulin × fasting free fatty acids).


    The takeaway: metabolic risk is determined by fat cell biology, not simply fat mass.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    Timestamps (approximate):

    01:00 — The U.S.–Singapore Metabolic Paradox

    04:22 — Hypertrophy vs. Hyperplasia: Why Fat Cell Size Matters

    07:52 — Insulin’s Anti-Lipolytic Role & Free Fatty Acids

    10:04 — When High Insulin and High FFAs Coexist

    12:19 — Ectopic Fat, Fatty Liver & the Diabetes Cascade

    15:21 — Hypoxia, HIF-1α & Inflammatory Fat Cells

    21:15 — The Adipose Expandability Hypothesis

    25:40 — The Personal Fat Threshold Explained

    32:06 — Why Universal BMI Cutoffs Fail

    37:54 — The Adipo-IR Index & Measuring Fat Cell Dysfunction


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • How Bile Controls Insulin, GLP-1, and Fat Burning

    How Bile Controls Insulin, GLP-1, and Fat Burning

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    Bile acids are powerful hormone-like signaling molecules that regulate liver fat, glucose production, insulin sensitivity, energy expenditure, inflammation, and GLP-1 release through FXR and TGR5 receptors. Gallbladder function and bile acid signaling play a far greater role in metabolic health than most people realize.


    Summary:

    Ben explores a largely overlooked metabolic regulator: bile acids. While bile is commonly understood as a digestive fluid that helps emulsify fats, bile acids are now recognized as powerful hormone-like signaling molecules that influence insulin sensitivity, mitochondrial function, thyroid hormone activation, inflammation, GLP-1 release, and fat cell behavior.


    Dr. Bikman explains the remarkable efficiency of enterohepatic circulation, where bile acids are reabsorbed and recycled multiple times per day. This recycling process allows bile acids to interact with key receptors — FXR (a nuclear receptor) and TGR5 (a G-protein coupled receptor) — triggering metabolic effects throughout the body.


    Activation of FXR reduces liver fat production, improves hepatic insulin sensitivity, lowers glucose output, and stimulates FGF19, which further suppresses excess glucose production. TGR5 activation increases energy expenditure via thyroid hormone activation in brown fat and muscle, stimulates GLP-1 release in the intestine, reduces inflammation in immune cells, and supports healthier adipose tissue signaling.


    Ben also examines the metabolic consequences of gallbladder removal. Without the gallbladder’s concentrated, timed bile release, signaling patterns change, and epidemiological data suggest increased risk of metabolic syndrome and fatty liver. Finally, Dr. Bikman discusses bile supplements such as ox bile and TUDCA, reviewing mechanistic rationale and human data showing improved insulin sensitivity in certain contexts.


    The overarching message: bile acids are not merely digestive detergents — they are among the most important and underappreciated metabolic signaling molecules in the body.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    #BileAcids #MetabolicHealth #FXR #TGR5 #Gallbladder #Cholecystectomy #InsulinResistance #GLP1 #TUDCA #OxBile #FatDigestion #Mitochondria #EnergyExpenditure #LiverHealth #FattyLiver #Type2Diabetes #MetabolismScience #HormoneHealth #BrownFat #DrBenBikman 


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

    Hosted on Acast. See acast.com/privacy for more information.

  • LDL Isn’t the Problem? The Real Drivers of Heart Disease

    LDL Isn’t the Problem? The Real Drivers of Heart Disease

    · The Metabolic Classroom with Dr. Ben Bikman

    📢 Ask Dr. Bikman’s Digital Mind (multilingual):

    https://benbikman.com/ben-bikmans-digital-ai-mind


    📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com


    Topic:

    LDL cholesterol is a weak predictor of heart disease compared to markers of insulin resistance, metabolic syndrome, and the triglyceride-to-HDL ratio. True cardiovascular risk is driven far more by metabolic dysfunction than by cholesterol numbers alone.


    Summary:

    In this episode, Ben challenges the long-standing belief that LDL cholesterol is the primary driver of heart disease. While LDL has dominated cardiovascular conversations for decades, large-scale data show that nearly half of people hospitalized with heart disease have “normal” LDL levels.


    Instead, the strongest predictors of cardiovascular risk — especially premature heart disease — are markers of metabolic dysfunction, particularly insulin resistance. Measures like the lipoprotein insulin resistance (LP-IR) score, type 2 diabetes status, metabolic syndrome, and even the simple triglyceride-to-HDL ratio dramatically outperform LDL cholesterol in predicting who will develop heart disease.


    One of the most practical tools discussed is the triglyceride-to-HDL ratio, which can be calculated from a standard lipid panel. This ratio reflects underlying insulin resistance and small, dense LDL particles far better than LDL levels alone.


    Dr. Bikman also reviews the modest benefits of statins in primary prevention and highlights a critical point: lowering LDL does not address the root metabolic dysfunction driving cardiovascular disease. In fact, statin use — particularly in women — may increase the risk of developing type 2 diabetes.


    The takeaway is clear: cardiovascular prevention should shift from being LDL-centric to metabolism-centric. Insulin sensitivity, triglycerides, HDL, fasting insulin, and glycemic control are far more powerful indicators of risk than LDL cholesterol alone.


    References:

    For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com


    NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.


    Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884


    Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb


    Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

    Hosted on Acast. See acast.com/privacy for more information.

  • Visa fler